In CHINA CINDA (01359): Wang Kunhui appointed as non-executive director.
China Sinopharm (01359) announced that Mr. Wang Kunhui has been appointed as a non-executive director of the company, approved by the shareholders at the extraordinary general meeting. Mr. Wang Kunhui will take office after the approval of his director qualifications by the China Banking and Insurance Regulatory Commission, with a term of three years.
CHINA CINDA (01359) announced that Mr. Wang Kunhui has been appointed as a non-executive director of the company, following approval at the extraordinary general meeting of shareholders. Mr. Wang Kunhui will assume the position after his directorship qualifications are approved by the China Banking and Insurance Regulatory Commission, with a term of three years.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


